Stay updated on Galcanezumab for Vestibular Migraine Clinical Trial
Sign up to get notified when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.

Latest updates to the Galcanezumab for Vestibular Migraine Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the study record display appears unchanged.SummaryDifference0.1%

- Check20 days agoChange DetectedA site-wide NIH notice announces a website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.7%

- Check27 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe website footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry (v3.7.0) is added to the study history, signaling an update to the record, while the prior revision (v3.6.6) is removed from the current history.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page’s version label was updated to Revision: v3.6.6, replacing the previous v3.6.5 tag to reflect a software update to the study history page.SummaryDifference0.1%

Stay in the know with updates to Galcanezumab for Vestibular Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.